Mohanad Albayyaa

ORCID: 0000-0003-4185-5294
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Urinary and Genital Oncology Studies
  • Colorectal Cancer Screening and Detection
  • Bladder and Urothelial Cancer Treatments
  • Systemic Sclerosis and Related Diseases
  • Systemic Lupus Erythematosus Research
  • Lymphatic Disorders and Treatments
  • COVID-19 Clinical Research Studies
  • Urinary Bladder and Prostate Research
  • Long-Term Effects of COVID-19
  • Lung Cancer Treatments and Mutations
  • Cancer Genomics and Diagnostics
  • Urinary Tract Infections Management
  • Hormonal and reproductive studies
  • Tumors and Oncological Cases
  • Sarcoma Diagnosis and Treatment
  • Urticaria and Related Conditions
  • Gastrointestinal disorders and treatments
  • Vascular Malformations and Hemangiomas
  • Pelvic floor disorders treatments
  • SARS-CoV-2 and COVID-19 Research
  • Skin Diseases and Diabetes
  • Cancer Diagnosis and Treatment
  • RNA modifications and cancer

The University of Texas Medical Branch at Galveston
2020-2024

Nahrain University
2018

Publishing its first issue in 2018, The Journal of Scientific Innovation Medicine is an open access, international, peer reviewed journal covering the range transformative scientific developments from bench, to bedside, and local global communities with emphasis on new concepts paradigms prevention treatment human disease creation health. mission this twofold. First, we advance understanding how apply technology, discovery innovative solutions order expand frontiers medicine welcomes...

10.29024/jsim.226 article EN cc-by Journal of Scientific Innovation in Medicine 2025-01-01

The use of statins, angiotensin-converting enzyme inhibitors (ACEIs)/angiotensin II receptor blockers (ARBs), and anticoagulants may be associated with fewer adverse outcomes in COVID-19 patients. Nested within a cohort 800,913 patients diagnosed between April 1, 2020 June 24, 2021 from the Optum database, three case-control studies were conducted. Cases—defined as persons who: (1) hospitalized 30 days diagnosis (n = 88,405); (2) admitted to intensive care unit (ICU)/received mechanical...

10.1016/j.ajmo.2023.100040 article EN cc-by American Journal of Medicine Open 2023-03-22

Abstract Prostate cancer ranks as the second most common cause of death among older men. Typically diagnosed at localized stages, treatment options primarily include radiation, hormonal therapy, or surgery. Androgen Deprivation Therapy (ADT) stands a cornerstone in prostate management, despite its association with various adverse effects such cardiovascular and autoimmune diseases. ADT alters mechanistic biological pathways androgens, impacting immune cell regulation equilibrium by...

10.1093/geroni/igae098.2312 article EN cc-by Innovation in Aging 2024-12-01

Background/Aim: Anaplastic Lymphoma Kinase (ALK) rearrangement has evaluated activity of NSCLC compared with other molecular subtypes (EGFR, KRAS). Many studies demonstrated that patients ALK positive have improved a good response rates and progression (free survival) when treated either monotherapy or by combination therapy EGFR-mutated, KRAS/EGFR/ALK wild type KRAS-mutated. The aim this study was to detect the signal pattern normal compare it mutated gene in cases non-small cell lung...

10.5539/cco.v7n1p22 article EN Cancer and Clinical Oncology 2018-01-12
Coming Soon ...